We invest in technology visionaries solving complex problems to reshape our world. Through a unique mix of expertise and resources, we build long-term partnerships with bold teams to accelerate their journeys.
At NVIDIA, we built and open-sourced Isaac™ Gym and Isaac Lab, and watched them become the backbone of robotic AI training across the industry. Now at Flexion, with NVentures’ support, we’re taking the next step: applying these same techniques at scale to deploy robots in real-world environments and deliver measurable impact.
— Nikita Rudin (Cofounder and CEO), Flexion
The next industrial revolution will be AI-native—and the next generation of hardware will be imagined, designed, and proven in software. The NVentures investment reflects our shared conviction of that future. The PhysicsX platform runs natively on NVIDIA accelerated computing and the NVIDIA CUDA-X™ stack, and integrates directly with NVIDIA PhysicsNeMo and NVIDIA Apollo alongside PhysicsX’s own Large Physics and Geometry Models. Together, these capabilities make production-ready physics AI possible.
— Jacomo Corbo (CEO and Cofounder), PhysicsX
We’re grateful for NVIDIA’s support as Redwood scales U.S.-built battery systems to power the rapidly growing demands of AI compute. Their investment helps accelerate our work to deploy dependable energy storage designed to keep AI factories running at speed and scale.
— JB Straubel (Founder and CEO), Redwood Materials
Couldn’t have wished for a better partner than NVIDIA and NVentures to build a generational company at the intersection of AI and biotech—deep technical support on foundation model training and acceleration, an unmatched ecosystem of partners and peers, and a shared vision for the future of making medicines.
Pioneering biological software, a new class of medicine and biotechnologies in which molecules are programmed to perform specific functions native to biological systems
Enterprise-grade technology that transforms patient-clinician conversations into structured clinical notes in real time with deep electronic medical record integrations
A biotechnology company integrating experimentation at scale and generative AI to improve the speed, cost, and success rate of small-molecule drug discovery and development